Fulvestrant Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GTHX | A | G1 Therapeutics, Inc. | 0.00 | |
OLMA | F | Olema Pharmaceuticals, Inc. | 0.78 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARB | A | AltShares Merger Arbitrage ETF | 1.72 | |
EVNT | B | AltShares Event-Driven ETF | 0.77 | |
BBC | B | Virtus LifeSci Biotech Clinical Trials ETF | 0.74 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 0.46 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 0.42 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Oct 31 | OLMA | Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation |
- Fulvestrant
Fulvestrant, sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.Fulvestrant is a selective estrogen receptor degrader (SERD) and was first-in-class to be approved. It works by binding to the estrogen receptor and destabilizing it, causing the cell's normal protein degradation processes to destroy it.Fulvestrant was approved for medical use in the United States in 2002.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles